Brian A. Leuthner
2017 - Edge Therapeutics
In 2017, Brian A. Leuthner earned a total compensation of $2.5M as President and Chief Executive Officer at Edge Therapeutics, a 37% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $255,000 |
|---|---|
| Option Awards | $1,761,831 |
| Salary | $500,000 |
| Other | $10,800 |
| Total | $2,527,631 |
Leuthner received $1.8M in option awards, accounting for 70% of the total pay in 2017.
Leuthner also received $255K in non-equity incentive plan, $500K in salary and $10.8K in other compensation.
Rankings
In 2017, Brian A. Leuthner's compensation ranked 4,378th out of 14,666 executives tracked by ExecPay. In other words, Leuthner earned more than 70.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,378 out of 14,666 | 70th |
Division Manufacturing | 1,539 out of 5,770 | 73rd |
Major group Chemicals And Allied Products | 444 out of 2,074 | 79th |
Industry group Drugs | 340 out of 1,730 | 80th |
Industry Pharmaceutical Preparations | 268 out of 1,329 | 80th |
Source: SEC filing on April 25, 2018.
Leuthner's colleagues
We found four more compensation records of executives who worked with Brian A. Leuthner at Edge Therapeutics in 2017.